SERPINA1 rs28934578: Understanding the Z Allele and AAT Deficiency

What each genotype means

What is the rs28934578 Variant?

The variant rs28934578 is a specific change in the DNA sequence of the SERPINA1 gene. In the scientific literature, this is frequently referred to as the 'Z' allele. This genetic change results in a single amino acid substitution in the alpha-1 antitrypsin protein, which is produced primarily in the liver. Because this variant was identified through protein analysis long before modern genomic sequencing, it carries a unique historical nomenclature. The Z allele is one of the most significant variants studied in the context of AATD, as it alters the structure of the protein, causing it to misfold and accumulate within liver cells rather than being released into the bloodstream to perform its protective functions. Understanding this variant requires looking at how it affects protein stability and the subsequent physiological impact on the body's ability to regulate inflammation.

The Role of the SERPINA1 Gene

The SERPINA1 gene provides instructions for making a protein called alpha-1 antitrypsin (AAT). This protein acts as a protease inhibitor, meaning it protects the body's tissues from damage caused by enzymes released during inflammation. Specifically, AAT helps neutralize elastase, an enzyme that can break down connective tissue in the lungs. When the SERPINA1 gene functions normally, AAT is secreted by the liver and travels through the blood to the lungs, where it maintains the integrity of the air sacs. If the gene carries variants like rs28934578, the resulting AAT protein may be dysfunctional or produced in insufficient quantities. This deficiency leaves tissues, particularly in the lungs, more vulnerable to damage from environmental factors like smoke or pollutants, and can lead to the accumulation of abnormal protein in the liver, which may cause cellular stress.

Research and Clinical Associations

Research has established a strong association between the presence of the Z allele and alpha-1 antitrypsin deficiency. Individuals who inherit two copies of this variant are at a significantly higher risk for developing chronic obstructive pulmonary disease (COPD), particularly emphysema, and liver disease, such as cirrhosis. The evidence for this association is robust, as the Z allele is a primary driver of severe AATD cases globally. However, the clinical expression of this variant can be highly variable; not everyone with the Z allele will develop severe disease. Factors such as smoking status, environmental exposures, and other genetic modifiers play a crucial role in determining health outcomes. Because the evidence is well-documented in clinical genetics, it is considered a high-attention variant in diagnostic settings, though it is important to remember that genetic status is only one piece of a complex health puzzle.

Population Frequency and Distribution

The frequency of the rs28934578 variant varies significantly across different ancestral groups. It is most commonly observed in populations of European descent, where the minor allele frequency is typically estimated between 0.015 and 0.02. In these populations, the prevalence of the Z allele is high enough that it is a standard target for genetic screening in individuals presenting with unexplained lung or liver symptoms. Conversely, the variant is much less common in non-European ancestries, including those of African, Asian, and Indigenous American descent. This distribution pattern highlights the importance of considering ancestral background when interpreting genetic test results. Because the variant is relatively rare in many parts of the world, it is often underdiagnosed in diverse populations, leading to ongoing research efforts to better understand its global impact and the spectrum of AATD across different genetic backgrounds.

Navigating Your Genetic Information

If you have received information about your status regarding the rs28934578 variant, it is important to approach this data with context. Knowing your genotype does not provide a definitive medical diagnosis, as many factors influence how a gene variant affects your health. You cannot change your genetic code, but you can use this information to make informed lifestyle choices, such as avoiding lung irritants like tobacco smoke, which can exacerbate the risks associated with AATD. If you are concerned about your results or have a family history of lung or liver disease, the most appropriate step is to consult with a healthcare professional or a genetic counselor. They can help interpret your results in the context of your overall health and family history. Never use genetic data to make independent medical decisions or to alter prescribed treatments without professional guidance.

Frequently asked questions

Sources & further reading

Related variants in SERPINA1